Lactobacillus Lozenges as Preventative Care in Low-grade Dysplasia

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 29, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
Low-grade Oral Dysplasia
Interventions
BIOLOGICAL

Probiotic oral lozenges

Participants in this arm will be be instructed to take a lozenge daily for 6 weeks. They will also receive oral dysplasia standard of care.

OTHER

Standard of care for oral dysplasia

Oral dysplasia standard of care includes clinical surveillance and risk factor reduction (such as smoking cessation).

Trial Locations (1)

02118

Boston Medical Center, Boston

Sponsors
All Listed Sponsors
collaborator

University of Alabama at Birmingham

OTHER

lead

Boston Medical Center

OTHER

NCT05707702 - Lactobacillus Lozenges as Preventative Care in Low-grade Dysplasia | Biotech Hunter | Biotech Hunter